Thrombosis Emerges as Significant Risk for COVID-19 Patients

May 04, 2020

The idea that the risk of blood clots is greater for COVID-19 patients than other severely ill patients began emerging in early reports from China a few months ago.

“But the gravity of these clotting disorders in COVID-19 only became clear over the past three to four weeks as we’ve started seeing these patients here,” says Behnood Bikdeli, MD, MS, a cardiovascular medicine fellow at Columbia University Irving Medical Center and a specialist in thrombosis. 

Bikdeli and Mahesh Madhavan, MD, another Columbia cardiology fellow, gathered more than 40 experts in cardiology and thrombosis from around the world to create consensus guidelines for treating clots in COVID-19 patients